Navigation Links
Top Genetic and Cellular Researchers Honored at ASGCT 16th Annual Meeting
Date:5/11/2013

Salt Lake City, UT (PRWEB) May 11, 2013

The American Society of Gene & Cell Therapy (ASGCT) is honored to recognize two leading researchers for their contributions to the genetic and cellular field at its 16th Annual Meeting to be held in Salt Lake City.

Dr. Mark Kay (Stanford University School of Medicine) will receive the ASGCT Outstanding Achievement Award for his nearly 20 years of dedication to the field of gene and cell therapeutics. His numerous demonstrations in pioneering research have also made him a recognized author with over 10,000 referenced journal citations. As a true leader not only in research, but within the Society as a whole, Kay was an original founding member as well as a past president of ASGCT. Dr. Kay’s Outstanding Achievement Award Lecture will take place on Friday, May 17, from 8:00am-9:00am.

The ASGCT Special Recognition Award is also given in acknowledgement and appreciation of an individual’s many scientific contributions and dedication to not only the Society itself, but to the field of gene and cell therapy. Dr. John Rossi, from the Beckman Research Institute City of Hope, is the Society’s 2013 recipient. Dr. Rossi’s leadership role in educating others within the Society, as well as his influence in their research yields significant respect and appreciation.

The American Society of Gene & Cell Therapy (ASGCT) is a professional nonprofit medical and scientific organization dedicated to the understanding, development and application of
genetic and cellular therapies and the promotion of professional and public education in the field. For more information on ASGCT, visit its website, http://www.asgct.org.

###

Read the full story at http://www.prweb.com/releases/2013/5/prweb10723792.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Interleukin Genetics Reports Third Quarter 2011 Financial Results
2. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
3. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
4. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
5. Cytogenetics - Technologies, Markets and Companies
6. 23andMe Presents Top Ten Most Interesting Genetic Findings of 2011
7. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
8. deCODE Genetics, in Collaboration with Academic Colleagues, Discovers Three Variants in the Sequence of the Human Genome that Affect the Risk of Thyroid Cancer
9. GeneThera, Inc. Acquires Applied Genetics, S.A.
10. Genetics Policy Institute (GPI) Files Additional Legal Arguments in Sherley v. Sebelius Stem Cell Case
11. Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017 For today, Stock-Callers.com ... novel drug development and clinical research aimed at treating diseases ... (NASDAQ: BSTG), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Kite Pharma Inc. ... ). You can access our complimentary research reports on these ... ...
(Date:4/19/2017)... , ... April 19, 2017 , ... Nobilis Therapeutics ... , Company Seeks to Leverage Clinical Data in its Upcoming Post Traumatic Stress Disorder ... of an 81 patient clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic ...
(Date:4/19/2017)... Calif. , April 19, 2017  As ... Drug Abuse and Heroin Summit ,  Proove® Biosciences, ... study analyzing genetics, environmental, and lifestyle factors to ... from the University of Southern California (USC), the ... , and Proove publish results showing that Proove ...
(Date:4/18/2017)... ... April 18, 2017 , ... CallTower, an ... Next-Gen Solution Provider. , Channel Partners program recognizes IT and telecom channel leaders ... and advocacy of the channel during transition and convergence. CallTower is the first ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):